Lichen China
LICN
6 hedge funds and large institutions have $445K invested in Lichen China in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
5% more capital invested
Capital invested by funds: $422K → $445K (+$22.7K)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.62K |
| 2 |
HF
HRT Financial
New York
|
+$1.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24.6K |
| 2 |
VF
Virtu Financial
New York
|
-$20K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$14.6K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MG
1
Marex Group
London,
| $224K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $87.4K | -$24.6K | -64 | -21% |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $66.6K | -$1.16K | -3 | -2% |
|
|
4
UBS Group
Zurich,
Switzerland
| $33.6K | -$14.6K | -38 | -29% |
|
|
HF
5
HRT Financial
New York
| $29K | +$1.92K | +5 | +6% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.43K | +$4.62K | +12 | New |
|
|
VF
7
Virtu Financial
New York
| – | -$20K | -69 | Closed |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$19.8K | -68 | Closed |
|
LICN Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q3 2024, worth a combined $445K — up 5.4% from $422K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LICN and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $4.62K. The largest seller was Citadel Advisors, cutting an estimated $24.6K.
- 6 institutional investors held Lichen China (LICN) as of Q3 2024, down from 7 in Q2 2024.
- Funds reported $445K of Lichen China stock for Q3 2024, up 5.4% quarter-over-quarter.
- 1 fund opened new Lichen China positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Lichen China buyer in Q3 2024 was Tower Research Capital (TRC), an estimated $4.62K added.
- The largest Lichen China seller in Q3 2024 was Citadel Advisors, an estimated $24.6K sold.
Based on aggregated 13F filings for Q3 2024.